Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04841551 · ClinicalTrials.gov registry record · Phase 4
Kybella for the Treatment of Flank Fat (FF)
A Phase 4 study of Adiposity, sponsored by Beer, Kenneth R., M.D., PA.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT04841551 is a Phase 4 study of Adiposity that has completed, run by Beer, Kenneth R., M.D., PA. The registered enrollment target is 10 participants, below the 100-participant average among 11 other Adiposity trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04841551, a Phase 4 study of Adiposity, has completed, sponsored by Beer, Kenneth R., M.D., PA.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
To Determine the safety and Effectiveness of Kybella for the treatment of Flank Fat (FF)
Conditions Studied
Interventions
- DRUG Kybella Flanks
Study Locations (1)
Florida
- Kenneth Beer, MD, PA - West Palm Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-07-22 |
| Est. Completion | 2022-03-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04841551
The ClinicalTrials.gov registry entry for NCT04841551 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 100-participant average among 11 other Adiposity trials with a reported enrollment target (90% lower). The listed sponsor is Beer, Kenneth R., M.D., PA, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Adiposity appearing as the primary indexed condition, and to 1 intervention - of which Kybella Flanks is the first listed.
NCT04841551 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04841551 about?
NCT04841551 is a clinical study titled "Kybella for the Treatment of Flank Fat (FF)". To Determine the safety and Effectiveness of Kybella for the treatment of Flank Fat (FF)
What is the current status of trial NCT04841551?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2021-07-22. Estimated completion is 2022-03-02.
What conditions does trial NCT04841551 study?
This clinical trial studies the following conditions: Adiposity.
What interventions are being tested in trial NCT04841551?
The interventions under investigation include: Kybella Flanks (DRUG).
Who is sponsoring clinical trial NCT04841551?
This trial is sponsored by Beer, Kenneth R., M.D., PA, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04841551 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adiposity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cardiometabolic Consequences of the Loss of Ovarian Function
RECRUITING · Phase 4
-
Kybella With Triamcinolone
COMPLETED · Phase 4
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Redefining BMI: The Body, Mind, and Inflammation Trial
RECRUITING · NA
-
The Sweet Kids Study (Stevia on Weight and Energy Effect Over Time)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.